The vision of BIODOT is a hybrid bio-organic technology for transduction of dynamical phenomena of biosystems in-vitro. The device that will be developed is based on organic ultra thin film transistors integrated with microfluidics.
The Biologically Inspired Materials Institute (BIMat) was established by NASA under the University Research, Engineering and Technology Institute (URETI) program. The principal goal for BIMat researchers is to develop bio-nanotechnology materials and structures for aerospace vehicles.
This EU project seeks to provide Europe with a major time advantage over their main international competitors by developing a bionanotechnological device that can be used as a nanoactuator/biosensor, which also provides a novel interface between the Biological and Silicon Worlds.
BioNanoNet is a bionanotechnology network in Austria that carries out innovative interdisciplinary research in the field of drug development. Within this network new agents, action and application strategies are being developed by using techniques of nanotechnology. Research efforts are aimed at finding new agents and new treatment strategies for chronic degenerative and infectious diseases.
The BIOTEX project aims at developing dedicated biochemical-sensing techniques compatible with integration into textile. The consortium includes two research institutes in the field of micro and nanotechnology.
Boeing Phantom Works is the advanced research and development unit at Boeing and the catalyst of innovation for the Boeing enterprise. For instance, they are working to create an entirely new class of nanostructured aluminum alloys. These lab-produced materials deliver titanium's strength - over a wide temperature range - in a much lighter material.
The mission of the group is to provide a rewarding and nourishing atmosphere of hands-on cutting edge research for students to develop and grow professionally and technically and use as an opportunity to springboard to a professional career that will benefit them and society.
The department has a strong record of research, with faculty involved in both experimental and theoretical areas. Some areas of current interest are: novel electronic materials; carbon nanotubes and nanotube arrays; theory of marginal Fermi liquids; optical and transport properties of low- dimensional condensed matter systems; novel superconductors.
Research in Optical Characterization and Nanophotonics (OCN) laboratory focuses on developing and applying advanced optical characterization techniques to the study of solid-state and biological phenomena at the nanoscale.
Highly interdisciplinary and translational, the group's research is focused on multifunctional, nanoparticle-based drug delivery systems. They seek to improve nanoparticle synthesis and formulation and its therapeutic efficacy. Additionally, they develop robust engineering processes to accelerate translation of nanoparticle-based drugs into the drug development pipeline. At the same time, they emphasize a fundamental understanding of the interface between nanomaterials and biological systems.
With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK.
The lab of Prof. Kenneth Breuer is active in research covering a wide variety of topics, including: Micron and nanometer scale fluid mechanics; Animal motion, in particular, bat flight and bacterial motility; Turbulent shear flows and shear flow control; Diagnostic methods for fluid mechanics.
The Institute for Molecular and Nanoscale Innovation (IMNI) was founded at Brown University in 2007 as an umbrella organization to support centers and collaborative research teams in targeted areas of the molecular and nanosciences. IMNI is a polydisciplinary venture with 55 faculty participants representing nine departments across campus. IMNI serves as a focal point for interaction with industry, government, and our affiliated hospitals.
Prof. Webster directs the Nanomedicine Laboratory which designs, synthesizes, and evaluates nanomaterials for various implant applications. Nanomaterials are central to the field of nanotechnology and are materials with one dimension less than 100 nm. Tissues investigated include bone, bladder, vascular, cartilage, dental, and the nervous system.
Nanofabrication manufacturing technology relates to the creation of microscopic structures. This technology is the basis of such diverse areas as computer chip manufacturing, flat panel displays and large scale solar power arrays used in space exploration, biological implants, medicine and pharmaceuticals. Rapid growth in these industries has created a strong demand for technicians with training in the intricacies of nanofabrication techniques and clean room procedures. Students enrolling in either program will spend three semesters on BCCC campus and the final capstone semester on Penn State campus.